Curious about what else BCC's AI Reports cover?
Get complimentary access to VerticalContext Chat - our AI-powered research platform - and explore the full suite of AI Reports free for 2 weeks.
Already a AI Vertical member? Login to access this report free.
Report Highlights
This report covers the impact of AI on targeted alpha therapies for cancer treatment market. It highlights how AI is reshaping the key industry verticals and how niche market players are investing in AI to gain control.
Report Includes
- An analysis of the AI impact on global market for targeted alpha therapies for cancer treatment
- Insights of the key Use Cases for AI implementation in developing personalized alpha radioligand therapies (ARTs)
- Understanding of AI adoption trends in RESS market across the four major global regions
- Impact analysis of AI on various stages of development of targeted alpha therapies for cancer, including drug discovery and development, clinical trials and optimization, and supply chain and manufacturing
- Impact of AI on various stages of the value chain for manufacturing and supply chain of radiopharmaceutical drugs
- Insights of the market spending and forecasting analysis of niche players
Report Scope
As reported by the World Health Organization (WHO), an estimated 9.7 million people died from cancer, and 20 million new cases were reported in 2022. It is reported that the global cancer cases will rise by 77% by the end of 2050, to a total of 35 million. Although traditional treatments such as radiotherapy, chemotherapy and surgery have made improvements, they frequently harm healthy tissues inadvertently. Radiopharmaceutical therapy (RPT) is a new approach that uses radioactive materials to target cancer cells while preserving healthy organs. AI can transform the process of developing new radiopharmaceuticals, enhance pharmacodynamics and streamline the drug discovery process. AI speeds up the process by using machine learning (ML) and deep learning (DL) approaches to identify targets faster, design molecules more effectively and develop better radiolabeling procedures. Radiopharmaceuticals will revolutionize healthcare, improve the quality of outcomes and open new avenues for precision medicine with the aid of AI.
Recent Reports
AI Impact on Noninvasive Cancer Diagnostics Market - BCC Pulse Report
This report provides an outlook of artificial intelligence impact on the global noninvasive cancer diagnostics market. It highlights major adoption trends of across the key geographic regions, and a review of market disruptions caused across several key industry verticals.
AI Adoption: A Global Perspective
This report provides an in-depth analysis of the current and future state of AI applications. Its scope includes a multifaceted review, covering both the technological progress driving AI and the various ways these developments are being used across different industries and by emerging businesses.
AI Use Case Analysis: Global Outlook
This report provides a comprehensive analysis of the current and future state of AI applications. Its scope includes a multifaceted review, covering both the technological progress driving AI and the various ways these developments are being used across different industries and by emerging businesses.
AI Impact on In Vitro Toxicity Testing - BCC Pulse Report
This report provides a brief overview of AI impact on in vitro toxicity testing market. It highlights major adoption trends across the key geographic regions, and disruptions caused across several key industry verticals.
AI Impact on Next Gen Active Materials Market - BCC Pulse Report
This report provides a brief overview of AI impact on next gen active materials market. It highlights major adoption trends across the key geographic regions, and disruptions caused across several key industry verticals.
Top Trending Reports
Global Markets for Diabetes Therapeutics and Diagnostics
The global market for diabetes therapeutics and diagnostics is estimated to grow from $134.9 billion in 2025 to reach $241.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.4% from 2025 through 2030.
Stem Cell and Regenerative Therapy: Global Markets
The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Data Center Networking Technologies: Global Markets
The global market for data center networking technologies is expected to grow from $45.8 billion in 2025 and is projected to reach $103 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2025 to 2030.
Plastics Recycling: Global Markets
The global market for plastics recycling was valued at $47.9 billion in 2025 and is estimated to reach $67.6 billion by 2030, at a compound annual growth rate (CAGR) of 7.1% from 2025 through 2030.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More